RDY vs SUN vs CAPL vs NGL vs MMLP

For growth investors, Dr.

Reddy's Laboratories Limited (RDY) is the stronger pick with 16. 6% revenue growth year-over-year, versus -16. 5% for NGL Energy Partners LP (NGL). Sunoco LP (SUN) offers the better valuation at 18. 5x trailing P/E (9. 4x forward), making it the more compelling value choice. Analysts rate Dr. Reddy's Laboratories Limited (RDY) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Sunoco LP (SUN) is the cheapest at 18.

5x versus CrossAmerica Partners LP at 19. 5x. On forward P/E, Dr. Reddy's Laboratories Limited is actually cheaper at 0. 2x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, NGL Energy Partners LP (NGL) delivered a total return of +626.

6%, compared to -2. 3% for Dr. Reddy's Laboratories Limited (RDY). Over 10 years, the gap is even starker: SUN returned +209. 2% versus MMLP's -57. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CrossAmerica Partners LP (CAPL) is the lower-risk stock at 0.

06β versus NGL Energy Partners LP's 0. 67β — meaning NGL is approximately 1105% more volatile than CAPL relative to the S&P 500. On balance sheet safety, Dr. Reddy's Laboratories Limited (RDY) carries a lower debt/equity ratio of 14% versus 4% for NGL Energy Partners LP — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Dr.

Reddy's Laboratories Limited (RDY) is pulling ahead at 16. 6% versus -16. 5% for NGL Energy Partners LP (NGL). On earnings-per-share growth, the picture is similar: CrossAmerica Partners LP grew EPS 109. 6% year-over-year, compared to -184. 6% for Martin Midstream Partners L. P.. Over a 3-year CAGR, RDY leads at 14. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Dr.

Reddy's Laboratories Limited (RDY) is the more profitable company, earning 17. 4% net margin versus -2. 0% for Martin Midstream Partners L. P. — meaning it keeps 17. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RDY leads at 22. 1% versus 3. 7% for SUN. At the gross margin level — before operating expenses — RDY leads at 58. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Dr.

Reddy's Laboratories Limited (RDY) trades at 0. 2x forward P/E versus 49. 5x for CrossAmerica Partners LP — 49. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SUN: 0. 3% to $68. 00.

All stocks in this comparison pay dividends.

NGL Energy Partners LP (NGL) offers the highest yield at 14. 3%, versus 0. 6% for Dr. Reddy's Laboratories Limited (RDY).

For long-horizon retirement investors, Sunoco LP (SUN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

13), 7. 1% yield, +209. 2% 10Y return). Both have compounded well over 10 years (SUN: +209. 2%, NGL: +78. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (RDY (Healthcare) and SUN (Energy) and CAPL (Energy) and NGL (Energy) and MMLP (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: RDY is a mid-cap high-growth stock; SUN is a small-cap income-oriented stock; CAPL is a small-cap income-oriented stock; NGL is a small-cap income-oriented stock; MMLP is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.